Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 13, 2026 14:56 ET | Source: Robbins LLP

INO Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Inovio Pharmaceuticals, Inc. Class Action

Robbins LLP is Investigating Allegations that Inovio Pharmaceuticals, Inc. (INO) Misled Investors Regarding Approval for its CELLECTRA Device
February 13, 2026 13:17 ET | Source: Robbins LLP

VTGN Investors with Large Losses Should Contact Robbins LLP for Information About Leading the Vistagen Therapeutics, Inc. Class Action

Robbins LLP is Investigating Allegations that Vistagen Therapeutics, Inc. (VTGN) Misled Investors Regarding the Viability of its Trial Study of Fasedieno
February 09, 2026 16:06 ET | Source: Robbins LLP

RARE Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Ultragenyx Pharmaceutical Inc. Class Action

Robbins LLP is investigating claims that Ultragenyx (RARE) misled investors about Phase III Orbit and Cosmic trials for setrusumab.
December 04, 2025 14:46 ET | Source: Robbins LLP

TLX Class Action Reminder: Telix Pharmaceuticals Ltd. Stockholders Should Contact Robbins LLP for Information About Leading the Class Action Against TLX

TLX Class Action Reminder: Telix Pharmaceuticals Ltd. Stockholders Should Contact Robbins LLP for Information About Leading the Class Action Against TLX
November 25, 2025 15:43 ET | Source: Robbins LLP

SKYE Stockholders with Large Losses Should Contact Robbins LLP for Information About Leading the Skye Bioscience, Inc. Class Action Lawsuit

SKYE Stockholders with Large Losses Should Contact Robbins LLP for Information About Leading the Skye Bioscience, Inc. Class Action Lawsuit
November 20, 2025 13:51 ET | Source: Robbins LLP

PRGO Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Perrigo Company plc Class Action

Robbins LLP is Investigating Allegations that Perrigo Company plc (PRGO) Misled Investors Regarding the Value of its Infant Formula Business
November 18, 2025 14:50 ET | Source: Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the Telix Pharmaceuticals Ltd. Securities Class Action

Robbins LLP is Investigating Allegations That Telix Pharmaceuticals Ltd. (TLX) Mislead Investors Regarding its Prostate Cancer Therapeutic Candidates
August 18, 2025 17:56 ET | Source: Robbins LLP

Robbins LLP Reminds Sarepta Therapeutics, Inc. Stockholders of the Pending Lead Plaintiff Deadline in the Securities Class Action Against SRPT

Robbins LLP is Investigating Allegations that Sarepta Therapeutics, Inc. (SRPT) Mislead Investors Regarding the Safety its ELEVIDYS Drug
August 14, 2025 19:25 ET | Source: Robbins LLP

Robbins LLP Urges NVO Stockholders with Large Losses to Contact the Firm for Information about Leading the Class Action Against Novo Nordisk A/S

Robbins LLP is Investigating Allegations that Novo Nordisk A/S (NVO) Misled the Market About its 2025 Revenue and Profit Growth Potential
July 25, 2025 15:22 ET | Source: Robbins LLP

BHVN Class Action Alert: Robbins LLP Reminds Biohaven Ltd. Stockholders of the Lead Plaintiff Deadline in the Class Action Against BHVN

Robbins LLP is Investigating Allegations that Biohaven Ltd. (BHVN) Misled Investors Regarding the Viability of its Candidate